This study extends diffusion weighted imaging at 21.1-T to identify the pattern of potential recovery of apparent diffusion coefficient (ADC) in rodent ischemic stroke with novel stem cell therapy using dissociated aggregate human mesenchymal stem cells (d-hMSC) from different donors. All scanning was performed at 21.1 T with the goal of quantitatively assessing treatment efficacy longitudinally, spanning a 3 weeks post ischemia. Results show donor resultant ADC discrepancies at various time points and regions.
This abstract and the presentation materials are available to members only; a login is required.